Drugs · acquisition-cost intelligence
Tramadol HCL ER
Tramadol HCL· ingredient tramadolOther opioids· TRAMADOL HYDROCHLORIDE 100 mg/1; TRAMADOL HYDROCHLORIDE 200 mg/1; TRAMADOL HYDROCHLORIDE 300 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$1.31
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other tramadol products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Tramadol HCL | $0.02365 | −$1.29 |
| Tramadol/APAP | $0.10548 | −$1.21 |
| ConZip | $8.94 | +$7.63 |
Medicare Part D coverage · CY2026
On 123 plan formularies · typical tier 3
Prior auth 46% · Step therapy 6% · Quantity limit 95% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.